Parasitosis and irritable bowel syndrome;Parasitosis y síndrome de intestino irritable

Revista Chilena de Infectologia

Volumn 33, Issue 3, 2016, Pages 268-274

  Ibarra, Catalina ^a   Herrera, Valentina ^a   De Arce, Edith Pérez ^b   Gil, Luis Carlos ^b   Madrid, Ana María ^c   Valenzuela, Lucía ^a   Beltrán, Caroll J ^d  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^c Laboratorio de Enfermedades Funcionales Digestivas   (Chile)

^d Laboratorio de Inmuno Gastroenterología   (Chile)

Author keywords

Blastocystis hominis; Entamoeba histolytica; Giardia intestinalis; Intestinal parasitosis; Irritable bowel syndrome; Post infection irritable bowel syndrome

Indexed keywords

AMEBIASIS; BLASTOCYSTIS HOMINIS; BLASTOCYSTOSIS; CHILE; COMPLICATION; ENTAMOEBA HISTOLYTICA; GIARDIA INTESTINALIS; GIARDIASIS; HUMAN; INTESTINE INFECTION; INTESTINE MUCOSA; IRRITABLE COLON; PARASITOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY;

BLASTOCYSTIS HOMINIS; BLASTOCYSTIS INFECTIONS; CHILE; ENTAMOEBA HISTOLYTICA; ENTAMOEBIASIS; GIARDIA LAMBLIA; GIARDIASIS; HUMANS; INTESTINAL DISEASES, PARASITIC; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME;

EID: 84984998186     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: 10.4067/S0716-10182016000300003     Document Type: Article

References (61)

1. Quigley E M, Abdel-Hamid H, Barbara G, Bhatia S J, Boeckxstaens G, De Giorgio R, et al. A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome. J Clin Gastroenterol 2012; 46 (5): 356-66.
2. Madrid-Silva A M, Defilippi-Caffri C, Landskron-Ramos G, Olguín-Herrera F, Reyes-Ponce A, Castro-Lara A, et al. The prevalence of irritable bowel symptoms in a population of shopping mall visitors in Santiago de Chile. Rev Gastroenterol Mex 2013; 78 (4): 203-10.
3. Monnikes H. Quality of life in patients with irritable bowel syndrome. J Clin Gastroenterol 2011; 45 Suppl: S98-101.
4. Canavan C, West J, Card T. Review article:the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther 2014; 40 (9): 1023-34.
5. Tanaka Y, Kanazawa M, Fukudo S, Drossman D A. Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil 2011; 17 (2): 131-9.
6. Stark D, van Hal S, Marriott D, Ellis J, Harkness J. Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. Int J Parasitol 2007; 37 (1): 11-20.
7. Apt W. Epidemiología y parasitosis. In: McGraw-Hill, editor. Parasitología Humana. 1° ed. Santiago, Chile 2013. p. 104-13.
8. Vigilancia de diarreas por agentes parasitarios en menores de 5 años. Chile 2008-2012. Boletín Instituto de Salud Pública de Chile. 2012 http://www.ispch.cl/sites/default/files/ boletin_diarreas.pdf
9. Mercado R, Castillo D, Muñoz V, Sandoval L, Jercic M I, Gil L C. Infecciones por protozoos y helmintos intestinales en pre-escolares y escolares de la Comuna de Colina, Santiago, Chile. Parasitol Latinoam 2003; 58: 173-6.
10. Vidal S, Toloza L, Cancino B. Evolution of the prevalence the enteroparasitoses in Talca-Chile. Rev Chilena Infectol 2010; 27 (4): 336-40.
11. Lee Y J, Park K S. Irritable bowel syndrome:emerging paradigm in pathophysiology. World J Gastroenterol 2014; 20 (10): 2456-69.
12. Rome-Foundation. Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. http:// wwwromecriteriaorg/criteria/.2006.
13. Longstreth G F, Thompson W G, Chey W D, Houghton L A, Mearin F, Spiller R C. Functional bowel disorders. Gastroenterology 2006; 130 (5): 1480-91.
14. Ohman L, Tornblom H, Simren M. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS. Nat Rev Gastroenterol Hepatol 2015; 12 (1): 36-49.
15. Gazouli M, Wouters M M, Kapur-Pojskic L, Bengtson M B, Friedman E, Nikcevic G, et al. Lessons learned-resolving the enigma of genetic factors in IBS. Nat Rev Gastroenterol Hepatol 2016; 13 (2): 77-87.
16. Rajilic-Stojanovic M, Jonkers D M, Salonen A, Hanevik K, Raes J, Jalanka J, et al. Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? Am J Gastroenterol 2015; 110 (2): 278-87.
17. Vicario M, González-Castro A M, Martínez C, Lobo B, Pigrau M, Guilarte M, et al. Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations. Gut 2015; 64 (9): 1379-88.
18. Moloney R D, Johnson A C, O’Mahony S M, Dinan T G, Greenwood-Van Meerveld B, Cryan J F. Stress and the microbiota-gut-brain axis in visceral pain: relevance to irritable bowel syndrome. CNS Neurosci Ther 2016; 22 (2): 102-17.
19. Thabane M, Marshall J K. Post-infectious irritable bowel syndrome. World J Gastroenterol 2009; 15 (29): 3591-6.
20. Grover M, Camilleri M, Smith K, Linden D R, Farrugia G. On the fiftieth anniversary. Postinfectious irritable bowel syndrome:mechanisms related to pathogens. Neurogastroenterol Motil 2014; 26 (2): 156-67.
21. Chaudhary N A, Truelove S C. The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases. Q J Med 1962; 31: 307-22.
22. Motomura Y, Khan W I, El-Sharkawy R T, Verma-Gandhu M, Grencis R K, Collins S M. Mechanisms underlying gut dysfunction in a murine model of chronic parasitic infection. Am J Physiol Gastrointest Liver Physiol 2010; 299 (6): G1354-60.
23. Beatty J K, Bhargava A, Buret A G. Postinfectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection. World J Gastroenterol 2014; 20 (14): 3976-85.
24. Ohman L, Isaksson S, Lindmark A C, Posserud I, Stotzer P O, Strid H, et al. T-cell activation in patients with irritable bowel syndrome. Am J Gastroenterol 2009; 104 (5): 1205-12.
25. Dinan T G, Quigley E M, Ahmed S M, Scully P, O’Brien S, O’Mahony L, et al. Hypothalamicpituitary- gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 2006; 130 (2): 304-11.
26. Liebregts T, Adam B, Bredack C, Roth A, Heinzel S, Lester S, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007; 132 (3): 913-20.
27. Dunlop S P, Jenkins D, Spiller R C. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003; 98 (7): 1578-83.
28. Bercik P, Wang L, Verdu E F, Mao Y K, Blennerhassett P, Khan W I, et al. Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. Gastroenterology 2004; 127 (1): 179-87.
29. Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell G S, Santini D, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126 (3): 693-702.
30. Lee Y A, Nam Y H, Min A, Kim K A, Nozaki T, Saito-Nakano Y, et al. Entamoeba histolytica-secreted cysteine proteases induce IL-8 production in human mast cells via a PAR2-independent mechanism. Parasite 2014; 21: 1.
31. Hardin J A, Buret A G, Olson M E, Kimm M H, Gall D G. Mast cell hyperplasia and increased macromolecular uptake in an animal model of giardiasis. J Parasitol 1997; 83 (5): 908-12.
32. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136 (6): 1979-88.
33. Madrid A M. Gil L C, Defilippi C L, Lanskron G, Castro A. ¿Debemos estudiar infección intestinal por parásitos en pacientes con Síndrome de Intestino Irritable? Rev Gastroenterología Latinoamericana 2011; 22 (1): 44.
34. Apt W. Blastocistiasis. In: McGraw-Hill, editor. Parasitología Humana. 1° ed. Santiago, Chile 2013. p. 152-4.
35. Wawrzyniak I, Poirier P, Viscogliosi E, Dionigia M, Texier C, Delbac F, et al. Blastocystis, an unrecognized parasite: an overview of pathogenesis and diagnosis. Ther Adv Infect Dis 2013; 1 (5): 167-78.
36. Poirier P, Wawrzyniak I, Vivares C P, Delbac F, El Alaoui H. New insights into Blastocystis spp:a potential link with irritable bowel syndrome. PLoS Pathog 2012; 8 (3): e1002545.
37. Giacometti A, Cirioni O, Fiorentini A, Fortuna M, Scalise G. Irritable bowel syndrome in patients with Blastocystis hominis infection. Eur J Clin Microbiol Infect Dis 1999; 18 (6): 436-9.
38. Jiménez-González D E, Martínez-Flores W A, Reyes-Gordillo J, Ramírez-Miranda M E, Arroyo-Escalante S, Romero-Valdovinos M, et al. Blastocystis infection is associated with irritable bowel syndrome in a Mexican patient population. Parasitol Res 2012; 110 (3): 1269-75.
39. Yakoob J, Jafri W, Beg M A, Abbas Z, Naz S, Islam M, et al. Irritable bowel syndrome: is it associated with genotypes of Blastocystis hominis. Parasitol Res 2010; 106 (5): 1033-8.
40. Dogruman-Al F, Simsek Z, Boorom K, Ekici E, Sahin M, Tuncer C, et al. Comparison of methods for detection of Blastocystis infection in routinely submitted stool samples, and also in IBS/IBD patients in Ankara, Turkey. PLoS One 2010; 5 (11): e15484.
41. Yakoob J, Jafri W, Jafri N, Khan R, Islam M, Beg M A, et al. Irritable bowel syndrome:in search of an etiology: role of Blastocystis hominis. Am J Trop Med Hyg 2004; 70 (4): 383-5.
42. Yakoob J, Jafri W, Beg M A, Abbas Z, Naz S, Islam M, et al. Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria. Parasitol Res 2010; 107 (3): 679-84.
43. Tungtrongchitr A, Manatsathit S, Kositchaiwat C, Ongrotchanakun J, Munkong N, Chinabutr P, et al. Blastocystis hominis infection in irritable bowel syndrome patients. Southeast Asian J Trop Med Public Health 2004; 35 (3): 705-10.
44. Ramírez-Miranda M E, Hernández-Castellanos R, López-Escamilla E, Moncada D, Rodríguez-Magallan A, Pagaza-Melero C, et al. Parasites in Mexican patients with irritable bowel syndrome:a case-control study. Parasit Vectors 2010; 3: 96.
45. Surangsrirat S, Thamrongwittawatpong L, Piyaniran W, Naaglor T, Khoprasert C, Taamasri P, et al. Assessment of the association between Blastocystis infection and irritable bowel syndrome. J Med Assoc Thai 2010; 93 Suppl 6: S119-24.
46. Morgan D R, Benshoff M, Cáceres M, Becker-Dreps S, Cortés L, Martin C F, et al. Irritable bowel syndrome and gastrointestinal parasite infection in a developing nation environment. Gastroenterol Res Pract 2012; 2012: 343812. doi: 10.1155/2012/343812. Epub 2012 Feb 19.
47. Thibeaux R, Weber C, Hon C C, Dillies M A, Ave P, Coppee J Y, et al. Identification of the virulence landscape essential for Entamoeba histolytica invasion of the human colon. PLoS Pathog 2013; 9 (12): e1003824.
48. Chacin-Bonilla L. An update on amebiasis. Rev Med Chile 2013; 141 (5): 609-15.
49. Stewart G T. Post-dysenteric colitis. Br Med J 1950; 1 (4650): 405-9.
50. Nanda R, Baveja U, Anand B S. Entamoeba histolytica cyst passers: clinical features and outcome in untreated subjects. Lancet 1984; 2 (8398): 301-3.
51. Anand A C, Reddy P S, Saiprasad G S, Kher S K. Does non-dysenteric intestinal amoebiasis exist? Lancet 1997; 349 (9045): 89-92.
52. Sinha P, Ghoshal U C, Choudhuri G, Naik S, Ayyagari A, Naik S R. Does Entamoeba histolytica cause irritable bowel syndrome? Indian J Gastroenterol 1997; 16 (4): 130-3.
53. Apt W. Giardiasis. In: McGraw-Hill, editor. Parasitología Humana. 1° ed. Santiago, Chile 2013. p. 145-51.
54. Halliez M C, Buret A G. Extra-intestinal and long term consequences of Giardia duodenalis infections. World J Gastroenterol 2013; 19 (47): 8974-85.
55. Gil L C, Hernández E, Madrid A M, Hurtado C, Castro A, Alcalde M. Parasitosis Intestinales ¿Una realidad vigente en nuestro medio? In: (SOCHIPA) SCdP, editor. XIV Jornadas Anuales de Parasitología; Santiago, Chile 2012. p. 44.
56. Grazioli B, Matera G, Laratta C, Schipani G, Guarnieri G, Spiniello E, et al. Giardia lamblia infection in patients with irritable bowel syndrome and dyspepsia: a prospective study. World J Gastroenterol 2006; 12 (12): 1941-4.
57. D’Anchino M, Orlando D, De Feudis L. Giardia lamblia infections become clinically evident by eliciting symptoms of irritable bowel syndrome. J Infect 2002; 45 (3): 169-72.
58. Wensaas K A, Langeland N, Hanevik K, Morch K, Eide G E, Rortveit G. Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study. Gut 2012; 61 (2): 214-9.
59. Hanevik K, Wensaas K A, Rortveit G, Eide G E, Morch K, Langeland N. Irritable bowel syndrome and chronic fatigue 6 years after giardia infection: a controlled prospective cohort study. Clin Infect Dis 2014; 59 (10): 1394-400.
60. Hanevik K, Hausken T, Morken M H, Strand E A, Morch K, Coll P, et al. Persisting symptoms and duodenal inflammation related to Giardia duodenalis infection. J Infect 2007; 55 (6): 524-30.
61. Morch K, Hanevik K, Rortveit G, Wensaas K A, Eide G E, Hausken T, et al. Severity of Giardia infection associated with post-infectious fatigue and abdominal symptoms two years after. BMC Infect Dis 2009; 9: 206.